Lv32
348 积分 2023-07-31 加入
OX40 enhances T cell immune response to PD-1 blockade therapy in non-small cell lung cancer
1个月前
已完结
Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance
1个月前
已完结
Lactate induces tumor-associated macrophage polarization independent of mitochondrial pyruvate carrier-mediated metabolism
1个月前
已完结
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
1个月前
已完结
Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
1个月前
已完结
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
2个月前
已完结
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
2个月前
已完结
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
2个月前
已完结
Targeted therapies for cancer
2个月前
已完结
Targeting mutations in cancer
2个月前
已完结
皖公网安备34019202002308
